The buyback is modest and primarily anti-dilutive, not a capital return signal. Monitor actual repurchase execution in future filings; the company is not obligated to buy any shares. The strong Q3 results and raised guidance are the more material events today.
Price Chart
Executive Summary
Bausch Health announced a $50 million share repurchase program to manage dilution from employee equity compensation, effective November 3, 2026 through November 3, 2027. The program is small relative to the company's $2.4B market cap (about 2.1%) and is not a signal of improving fundamentals. The announcement follows a strong Q3 earnings beat and raised guidance reported earlier today.
Key Financial Metrics
Key Facts
- Board authorized up to $50 million in share repurchases
- Program begins November 3, 2026 and ends November 3, 2027
- Primary objective is to manage dilutive impact of future employee equity-based compensation
- Company may not repurchase more than 5% of 374,266,716 outstanding common shares
- Purchases will be made in the open market at prevailing market prices
- All repurchased shares will be cancelled
- Program may be suspended, modified or discontinued at any time
Financial Impact
$50 million buyback authorization, approximately 2.1% of current market cap
Risk Factors
- Program is discretionary and may not be fully executed
- Buyback does not offset declining fundamentals in any segment
- Solta Medical segment posted a 4% organic decline in Q3
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302922572 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 2d ago | 8-K | $8.91 $8.20 | ▼ −7.97% | ▼ −6.20% | $8.20 (−7.97%) |
Oct 28, 2026 2d ago | Press Release | $8.91 $8.20 | ▼ −7.97% | ▼ −6.20% | $8.20 (−7.97%) |
Oct 6, 2026 24d ago | Press Release | $6.02 $6.15 | ▲ +2.16% | ▲ +2.40% | $8.20 (+36.21%) |
Aug 27, 2026 9w ago | Press Release | $6.30 $6.32 | ▲ +0.32% | ▲ +0.54% | $8.20 (+30.16%) |
Apr 8, 2026 29w ago | DEFA14A | $5.39 $5.60 | ▲ +3.90% | ▲ +3.96% | $8.20 (+52.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers